Indian Frankincense — the Ayurvedic Shallaki resin standardised into a clinical-grade anti-inflammatory ingredient
Boswellia serrata — known as Indian Frankincense, Salai Guggul, or Shallaki in Ayurveda — yields an oleo-gum-resin prized for centuries in joint and inflammatory care. Its activity comes from a family of pentacyclic triterpenic acids called boswellic acids, of which AKBA (acetyl-11-keto-β-boswellic acid) is the most potent — a selective inhibitor of 5-lipoxygenase, the enzyme that drives pro-inflammatory leukotriene synthesis.
SV Botanica supplies Boswellia Dry Extract standardised to a minimum of 65% total boswellic acids by titration — the representative batch (SVB/BS/2602-01) assays at 75.58%. The extract is processed from the resin of wild-harvested Boswellia serrata in India at our GMP-certified facility, then screened by ICP-MS for heavy metals and a full USP microbial panel before release.
For brands targeting the most-studied marker, we offer AKBA-enriched grades standardised by HPLC to 10%, 20% and 30% AKBA, alongside higher total-acid grades at 75%, 85% and 90%. Kosher certification is standard.
We supply joint-health, anti-inflammatory, sports-nutrition and Ayurvedic manufacturers across Europe, the USA, the Middle East and Southeast Asia. Every batch is backed by a Certificate of Analysis and full export documentation — start a conversation with our team via the quote request form.
